Equities

Poolbeg Pharma PLC

POLB:LSE

Poolbeg Pharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)7.75
  • Today's Change0.15 / 1.97%
  • Shares traded1.25m
  • 1 Year change-20.51%
  • Beta2.9034
Data delayed at least 20 minutes, as of Nov 22 2024 16:28 GMT.
More ▼

Forecasts data is unavailable for this security.

Share price forecast

The 2 analysts offering 12 month price targets for Poolbeg Pharma PLC have a median target of 21.00, with a high estimate of 23.00 and a low estimate of 19.00. The median estimate represents a 176.32% increase from the last price of 7.60.
High202.6%23.00
Med176.3%21.00
Low150.0%19.00

Earnings history & estimates

Poolbeg Pharma PLC reported annual 2023 losses of -0.79 per share on Apr 30, 2024.
Average growth rate+15.96%
More ▼

Revenue history & estimates

Poolbeg Pharma PLC did not report revenues for the full year 2023. However, during the prior year the company reported revenues of 0.00.
Average growth rate0.00%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.